| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44952652d54854af6a6af9c3bd65b596 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55588
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-215 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2022-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06d836aaabe7731c579204e219d0f9a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17948c7bbcecb2cd4233f517496b560c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b271c4387f8d371d61fb0a38982832ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3f0b37efcea594170266574a96a206f |
| publicationDate |
2022-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2022231665-A1 |
| titleOfInvention |
Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use |
| abstract |
[0461] The present disclosure provides recombinantly manufactured fusion proteins comprising na SARS-CoV-2 Receptor Binding Domain (SARS-CoV-2-RBD) fragment or an analog thereof nlinked to a human Fc fragment for use in relation to the 2019 Novel Coronavirus (COVID-19). nEmbodiments include the administration of the fusion proteins to patients that have recovered nfrom COVID-19 as a booster vaccination, to antibody naive patients to produce antibodies to nthe SARS-CoV-2 virus to enable the patients to become convalescent plasma donors, to patients nwho have been infected by the SARS-CoV-2 virus and have contracted COVID-19 in order to nlimit the scope of the infection and ameliorate the disease, and as a prophylactic COVID-19 nvaccine. Exemplary Fc fusion proteins and pharmaceutical formulations of exemplary Fc fusion nproteins are provided, in addition to methods of use and preparation. |
| priorityDate |
2020-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |